HSG, formerly known as Sequoia Capital China, is a prominent venture capital and private equity firm with a global focus on technology, healthcare, and consumer sectors. Established in 2005, HSG operates offices in key international cities including Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore, managing over $55 billion in assets for leading institutional investors. The firm has supported over 1,500 companies, fostering innovation and entrepreneurship through investments in transformative technologies and high-growth business models. HSG has a track record of success, with more than 160 portfolio companies having gone public and over 140 achieving unicorn status. It has developed a comprehensive investment platform that encompasses seed, venture, growth, buyout, and infrastructure investing, as well as public equities. HSG is dedicated to empowering entrepreneurs and companies to create enduring enterprises while delivering strong returns to its limited partners. Through its extensive resources and industry expertise, HSG provides significant advantages to the companies it partners with.
2800 Sand Hill Road, Suite 101 Menlo Park, California 94025, USA
Room 3606 China Central Place Tower 3 77 Jianguo Road Chaoyang District Beijing 100025, China
6th Floor, East Wing, Block B, Divyasree Technopolis, Off HAL Airport Road, Yemalur, Kadubeesanahalli, Bengaluru, Karnataka 560037, India
Wang Chenyu
Vice President
Sakshi Chopra
Managing Director
Amit Jain
Managing Director
Cherry Lu
Partner
Ishaan Mittal
Managing Director
Enita Pu
Partner
Harshjit Sethi
Managing Director
Tejeshwi Sharma
Managing Director
Pavel Vyhnalek
Operating Partner
Fu Xin
Partner
Past deals in Shanghai
Naen Auto
Venture Round in 2024
Shanghai NAEN Auto Technology Co., Ltd. specializes in automotive electronics, focusing on the development and manufacturing of advanced products for automobile manufacturers. The company's offerings include a range of systems such as passive entry passive start (PEPS), electronic steering column locks (ESCL), smart air conditioning (AC), body control modules (BCM), heads-up display (HUD) systems, domain control units (DCU), capacitive sensors (CS), and kick sensors (KS). By providing these innovative solutions, NAEN Auto supports the production of intelligent vehicles, enhancing functionality and user experience in modern automobiles.
Xiaohongshu
Secondary Market in 2024
Xiaohongshu, founded in 2013 and based in Shanghai, is a lifestyle sharing platform that facilitates the exchange of experiences through text, images, and videos. Initially created to assist overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle topics, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform allows users to post their favorite products, share shopping experiences, and discover global merchandise, particularly in the luxury and fashion sectors. It serves as both a social network and a social e-commerce platform, enabling users to review and purchase products from abroad.
Xiaohongshu
Secondary Market in 2023
Xiaohongshu, founded in 2013 and based in Shanghai, is a lifestyle sharing platform that facilitates the exchange of experiences through text, images, and videos. Initially created to assist overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle topics, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform allows users to post their favorite products, share shopping experiences, and discover global merchandise, particularly in the luxury and fashion sectors. It serves as both a social network and a social e-commerce platform, enabling users to review and purchase products from abroad.
Neurophth Therapeutics
Series C in 2023
Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.
Micro Connect
Series C in 2023
Micro Connect is a financial market platform that specializes in connecting global capital with China's micro and small businesses. The company focuses on enhancing liquidity in small business investments by providing professional investors with a new alternative to traditional impact investing. Micro Connect introduces Daily Revenue Obligations (DROs), an innovative asset class that allows investors to gain direct and diversified exposure to the daily cash flows of numerous retail establishments within China's dynamic consumer market. By facilitating access to capital for business owners, Micro Connect aims to create a more affordable financial ecosystem, while also offering structured product solutions and operating a licensed exchange.
SUNRATE
Series D in 2023
SUNRATE is a global payment and treasury management platform established in 2016, designed to support businesses in scaling their operations both locally and internationally. With its headquarters in Singapore and additional offices in Hong Kong, Jakarta, London, and Shanghai, SUNRATE serves clients in over 190 countries and regions. The platform provides a variety of services, including international payments, virtual corporate cards, global collections, and comprehensive treasury management solutions. By partnering with leading financial institutions and leveraging advanced technology, SUNRATE facilitates smoother international trade for small and medium-sized enterprises, helping them navigate the complexities of global commerce.
PhaBuilder
Series A in 2023
PhaBuilder is a platform-based & product-based company with advanced technology in synthetic biology, focusing on the transformation and engineering application of halophilic microbes. PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainly uses the cutting-edge "Next Generation Industrial Biotechnology(NGIB)" to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor. PhaBuilder currently has two PHA plants under construction - the synthetic biology intelligent development plant in Beijing China-Germany Industrial Park and the 10 kt/annum plant in Yichang, Hubei Province. It also plans to build up 3-5 large-scale production bases throughout China within five years. At present, PhaBuilder has completed two rounds of financing, raising around 300 million yuan in total. The investors include Sequoia Capital, China State-owned Enterprise Mixed Ownership Reform Fund, and GRC SinoGreen Fund, etc. In the future, PhaBuilder will constantly promote synthetic biotechnology to deeply integrate with people's lives and upgrade the intelligent biological manufacturing industry, in order to achieve PhaBuilder's core mission of "Using microbes to change the world and build a green future".
Locad
Series A in 2023
Locad is a logistics provider that supports e-commerce brands in the Asia-Pacific region by offering a cloud-based supply chain solution. Its technology platform enables seamless inventory synchronization across various online sales channels and facilitates end-to-end order fulfillment through a network of warehouses and carriers in countries such as Singapore, the Philippines, Thailand, Hong Kong, and Australia. By leveraging a geographically distributed warehousing infrastructure, Locad allows brands to store products closer to their customers, resulting in quicker delivery times and reduced shipping costs. The platform provides easy integration with sales channels and offers on-demand capacity, making it adaptable to the varied needs of clients. With hundreds of brands utilizing its services, Locad aims to enhance shipping efficiency, lower expenses, and support significant business growth.
HAAWKING
Series A in 2022
HAAWKING is a developer and manufacturer of digital signal processors and microprocessors, specializing in applications for industrial control, motor drives, digital power supplies, photovoltaic systems, energy storage, and consumer electronics. Based in China, the company emphasizes research and development in its product offerings, which also include machine vision chips tailored for use in industrial robots and intelligent applications such as augmented reality and autonomous driving. HAAWKING aims to enhance computing efficiency and reduce costs for its clients across various sectors. Customers can reach out to the company through email and phone for inquiries and support.
Zhonghai Chuneng Technology Beijing
Seed Round in 2022
Zhonghai Chuneng Technology Beijing develops energy storage technology and the production, and sales of energy storage equipment.
Cataya Bio
Series A in 2022
Cataya Bio (Shanghai) Co., Ltd. is focused on developing synthetic biological products for diverse industries through its advanced engineering biology platform and biomanufacturing capabilities. The company engineers microbes and creates clean fermentation processes to produce high-purity products sustainably and cost-effectively. By leveraging synthetic biology technology, Cataya Bio enables clients to obtain natural and sustainable raw materials, contributing to a shift away from petroleum-based resources. The company's efforts address critical global challenges such as environmental preservation, carbon emissions, and climate change.
XellSmart
Series A in 2022
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.
Mech-Mind Robotics
Series C in 2022
Mech-Mind Robotics Technologies, founded in 2016 and based in Beijing, China, specializes in manufacturing smart cameras and developing AI-powered software for the logistics industry. The company produces a range of cameras, including the Mech-Eye Smart Camera, designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind's technology integrates 3D vision with artificial intelligence, enabling robots to recognize objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in addressing complex automation challenges, including logistics parcel picking and related operations. The company also maintains an office in Munich, Germany, and a sales office in Shanghai, China.
HAI ROBOTICS
Series D in 2022
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a variety of intelligent solutions, including a goods-to-person system, smart in-plant logistics solutions for manufacturing, and multi-tier steel platforms for diverse applications. As a pioneer in the field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, and has since focused on research and development, securing numerous patents. The HAIPICK system significantly enhances warehouse efficiency, reportedly increasing operational productivity by three to four times and boosting storage density by 80% to 130%. HAI ROBOTICS caters to a broad range of clients, including major logistics and supply chain companies, and is committed to delivering flexible and customizable automation solutions to optimize warehouse operations.
NuProbe
Series B in 2022
NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.
Supreium Technology
Series A in 2022
Supreium specializes in the development of computer-aided engineering (CAE) simulation software solutions tailored for intelligent manufacturing. Founded in 2016 and headquartered in Beijing, China, the company offers a software as a service (SaaS) platform that includes various services such as mold design, injection process analysis, and thermal balance assessments. Its offerings also encompass automatic defect detection through image scanning and process consulting services. Serving diverse sectors including medical treatment, marine water conservancy, communications, and industrial markets, Supreium is committed to advancing high-performance digital solutions through its innovative algorithms and cloud-native simulation technologies. The company is recognized for its focus on intelligent industrial design applications and is positioned at the forefront of CAE technology development.
EPiCMEMS
Series A in 2022
EPiCMEMS, a local chip company based in Xiamen, specializes in the development of RF front-end solutions, focusing on 4G+ and 5G RF filters and chips. The company aims to advance the domestic chip industry by producing high-speed, high-quality 5G chips tailored for mobile devices and the Internet of Things (IoT). With operational facilities in Xiamen and Zhangjiang, along with sales and customer support centers in Shenzhen, Xi'an, and Beijing, EPiCMEMS is committed to enhancing connectivity and stability for users across the mobile and IoT sectors.
KAWO 科握
Series A in 2022
KAWO is an enterprise SaaS Chinese social media management platform for WeChat, Weibo, Douyin & Kuaishou. KAWO connects teams across the globe providing data insights, greater transparency, and increased efficiency. We help international brands in China be more authentic and consistent on social media. Founded in 2013, KAWO’s experienced team is focused on delivering high-quality solutions allowing our clients to iterate fast in China’s rapidly changing social landscape. 科握将分布在全球的工作团队连接在一起,提供市场数据解读,增强流程透明化,提高团队效率。我们帮助国际品牌在中国树立更可靠的品牌形象并与其全球策略保持一致。 科握成立于2013年,我们富有经验的团队始终关注于提供高质量的解决方案,帮助我们的客户在快速变化的中国社媒营销市场中脱颖而出。
Shein
Series F in 2022
Shein is an online marketplace focused on women's apparel, offering a wide range of clothing, shoes, jewelry, and accessories. Founded in 2008 and headquartered in Jiangsu, China, the company utilizes on-demand manufacturing technologies to connect suppliers with an agile supply chain, effectively reducing inventory waste. This approach allows Shein to provide affordable fast fashion products to customers in over 220 countries and regions worldwide. By emphasizing accessibility and efficiency, Shein aims to make contemporary fashion more attainable for consumers globally.
Micro Connect
Series B in 2022
Micro Connect is a financial market platform that specializes in connecting global capital with China's micro and small businesses. The company focuses on enhancing liquidity in small business investments by providing professional investors with a new alternative to traditional impact investing. Micro Connect introduces Daily Revenue Obligations (DROs), an innovative asset class that allows investors to gain direct and diversified exposure to the daily cash flows of numerous retail establishments within China's dynamic consumer market. By facilitating access to capital for business owners, Micro Connect aims to create a more affordable financial ecosystem, while also offering structured product solutions and operating a licensed exchange.
XVERSE
Series A in 2022
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers. The company is located in Shenzhen, China.
Inceptio Technology
Series B in 2022
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.
WeShine
Series B in 2022
WeShine is a marketing and service platform that specializes in corporate account management solutions, primarily utilizing WeChat to enhance customer acquisition for businesses. Established in 2015 and headquartered in Nanjing, China, WeShine has successfully served over 150,000 businesses, with more than 30,000 of these being paid enterprise users. The platform focuses on integrated marketing and media services that leverage social media to enable mobile interaction and digital content sharing, helping clients to expand their customer base and improve marketing accuracy. With a global network of over 600 channel partners, WeShine operates offices in several major Chinese cities, including Guangzhou, Shenzhen, Beijing, Shanghai, Wuxi, and Wuhan.
Amber Group
Series B in 2022
Amber Group is a cryptocurrency financial services provider based in Hong Kong, established in 2017 by finance professionals from leading institutions. The company offers a range of services including liquidity provision, trading, asset management, yield enhancement, collateralized lending, decentralized finance, and electronic market making. Operating globally, Amber Group serves over 200 institutional clients and has facilitated cumulative trading exceeding $200 billion across numerous electronic exchanges, with an average daily trading volume of $100-200 million. The company is dedicated to enhancing client experiences by leveraging advanced technology and quantitative research, aiming to optimize investment flexibility and maximize returns. Amber Group has also raised significant capital to support its growth and innovation in the cryptocurrency space.
Modalku
Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia for small businesses to acquire loans and for lenders to fund small business loans to earn compelling returns. Its technology-based approach enables borrowers to receive loans for the first time or at lower than market rates, while lenders will earn returns well above that of bank deposits, traditional fixed income products, and life insurance investment-linked products. This marketplace lending model is proven in countries such as USA, UK, China & Singapore.
SceneRay
Series D in 2022
SceneRay Co. Ltd, based in Singapore Industrial Park, Suzhou, China, specializes in the design, development, and distribution of neuromodulation devices, particularly focusing on brain pacemakers. The company’s core team comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, both in China and internationally. SceneRay's product offerings include a dual-channel implantable pulse generator kit designed for deep brain stimulation, which provides therapeutic electric stimulation to address issues related to brain damage. Committed to innovation, SceneRay holds numerous patents and strives to deliver high-quality, effective treatments for patients.
Qianglian Zhichuang
Series C in 2022
the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.
Tongxin Medical Equipment
Series D in 2022
Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency
PhaBuilder
Venture Round in 2022
PhaBuilder is a platform-based & product-based company with advanced technology in synthetic biology, focusing on the transformation and engineering application of halophilic microbes. PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainly uses the cutting-edge "Next Generation Industrial Biotechnology(NGIB)" to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor. PhaBuilder currently has two PHA plants under construction - the synthetic biology intelligent development plant in Beijing China-Germany Industrial Park and the 10 kt/annum plant in Yichang, Hubei Province. It also plans to build up 3-5 large-scale production bases throughout China within five years. At present, PhaBuilder has completed two rounds of financing, raising around 300 million yuan in total. The investors include Sequoia Capital, China State-owned Enterprise Mixed Ownership Reform Fund, and GRC SinoGreen Fund, etc. In the future, PhaBuilder will constantly promote synthetic biotechnology to deeply integrate with people's lives and upgrade the intelligent biological manufacturing industry, in order to achieve PhaBuilder's core mission of "Using microbes to change the world and build a green future".
Vibrant
Venture Round in 2022
Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
Parametrix.ai
Series B in 2022
Parametrix.ai is a startup focused on transforming the gaming industry through advanced artificial intelligence solutions. Founded in 2019 and headquartered in China, the company specializes in the integration of AI capabilities into game scenarios, enhancing the development process and player experience. Its technology encompasses machine learning, reinforcement learning, and large system engineering, enabling complex environmental sensing, decision-making, and the creation of dynamic game elements such as teams and enemies. By fostering AI entities as native participants in virtual worlds, Parametrix.ai aims to collaboratively design immersive and inclusive gaming environments that engage players in innovative ways.
Treelab
Series A in 2021
Treelab is a Shanghai-based company founded in 2019 that offers a productivity tool designed to enable non-technical users to create custom business systems. Its platform allows organizations to develop personalized software solutions for various functions, including project management, sales CRM, human resource management, and form collection. Treelab's SaaS-based platform simplifies the management of products, suppliers, orders, and invoices while providing real-time progress tracking and collaboration features. By streamlining the sourcing process and facilitating the design of unique workflows, Treelab empowers clients to efficiently manage their business operations without the need for programming expertise.
Recurrent.ai
Venture Round in 2021
Recurrent.ai is a Chinese company that specializes in AI-enabled corporate services aimed at enhancing sales efficiency. The company offers a comprehensive sales dialogue analysis system that converts voice interactions into text, facilitating in-depth analysis of sales calls and customer service conversations. By leveraging machine learning, Recurrent.ai helps businesses generate detailed big data dialogue analysis reports and maintain customer portrait records. These capabilities enable companies to optimize their sales processes, reduce labor costs, and improve sales conversion rates, ultimately supporting more informed decision-making.
Tungee
Series B in 2021
Tungee, established in 2016, is a provider of intelligent sales solutions for business-to-business enterprises. By utilizing big data and artificial intelligence technologies, including natural language processing and machine learning, Tungee offers a comprehensive platform that facilitates lead mining, business opportunity engagement, customer relationship management, and order analysis. This platform is designed to help enterprises efficiently identify, contact, and manage customers, thereby reducing customer acquisition costs and enhancing overall sales performance. Tungee has positioned itself as a leader in the Chinese intelligent sales sector, serving over 3,000 enterprise clients, including notable companies such as Alibaba and China Mobile. Through its innovative approach, Tungee addresses the challenges faced by businesses in sales forecasting and customer management.
QianDao App
Series B in 2021
QianDao App is a Shanghai-based company that specializes in developing trading software for blind box toys and garage kits, targeting youth in China. Founded in 2019, the platform allows users to customize and order toys according to their personal preferences. Its main offerings include the Happy Train and Wedding Flower Girl series, catering to a community of garage kit enthusiasts and collectors. By providing a space for interaction and trade among users, QianDao App fosters a vibrant culture around these collectible items.
Beijing Sudo Technology
Series A in 2021
Beijing Sudo Technology provides privacy protection technical services from the perspective of systematic comprehensive engineering.
Neurophth Therapeutics
Series C in 2021
Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.
ThinkingData
Series C in 2021
Founded in 2015, ThinkingData is a mobile game product intelligence and analysis platform in China. The company is headquartered in Shanghai and has branches in Tokyo, and Singapore. Thinking Analytics (referred to as "TA System") independently researched and developed by ThinkingData, provides an integrated solution for Data Ingestion, Processing, Storage, Modeling, and Visualization. The platform supports full-spectrum data collection, multi-dimensional cross-analysis, and on-premise deployment, which can help companies deal with complex mobile game business scenarios and achieve refined operations and business growth. At present, ThinkingData has served 700+ mobile game customers, including famous game companies such as FunPlus, Kunlun Games, CMGE, Electronic Soul, and Hero Games. There are as many as 5000+ games integrated with the TA system, such as "Archero", "The Marvelous Snail", "Love Nikki", "Legend of the Ancient Sword" and other popular games in use.
Edge Medical Robotics
Series C in 2021
Edge Medical Robotics, Inc. was founded in Longgang, Shenzhen, China on May 4, 2017. It is committed to researching and promoting most advanced smart equipment in the world,polishing the ultimate product with the spirit of pursuing excellence and fineness, improving surgical safety and treatment efficacy, and contributing to uprising the level of social health.
Animoca Brands
Venture Round in 2021
Animoca Brands is a metaverse and gaming venture capital firm that focuses on driving digital property rights to gamers and internet users through NFTs. It utilizes gamification and blockchain to develop and market a portfolio of mobile applications, games, and additional products oriented to educational learning to ensure transparency, security, and new business models.
KAWO 科握
Seed Round in 2021
KAWO is an enterprise SaaS Chinese social media management platform for WeChat, Weibo, Douyin & Kuaishou. KAWO connects teams across the globe providing data insights, greater transparency, and increased efficiency. We help international brands in China be more authentic and consistent on social media. Founded in 2013, KAWO’s experienced team is focused on delivering high-quality solutions allowing our clients to iterate fast in China’s rapidly changing social landscape. 科握将分布在全球的工作团队连接在一起,提供市场数据解读,增强流程透明化,提高团队效率。我们帮助国际品牌在中国树立更可靠的品牌形象并与其全球策略保持一致。 科握成立于2013年,我们富有经验的团队始终关注于提供高质量的解决方案,帮助我们的客户在快速变化的中国社媒营销市场中脱颖而出。
Cellular Biomedicine Group
Series A in 2021
Cellular Biomedicine Group, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer and stem cell therapies for degenerative diseases, particularly in Greater China. The company utilizes proprietary cell-based technologies to create treatments, including various forms of CAR-T therapies targeting different cancer types, such as CD20 for anti-tumor activities, CD22 for B cell malignancies, and therapies aimed at refractory multiple myeloma. Additionally, the company develops NKG2D CAR therapies and treatments for hepatocellular carcinoma, alongside knee osteoarthritis therapies currently undergoing clinical trials. Beyond its therapeutic development, Cellular Biomedicine Group is involved in biopharmaceutical activities encompassing research and development, technical support, and the manufacturing of pharmaceutical products and medical devices. It also operates under a collaboration agreement with Novartis Pharma AG to manufacture and supply the CAR-T cell therapy Kymriah in China. Established in 2001, the company integrates over thirty years of research and clinical experience in cellular medicine, drawing on expertise from collaborations among scientists and medical professionals across the United States, England, and China.
Mech-Mind Robotics
Series C in 2021
Mech-Mind Robotics Technologies, founded in 2016 and based in Beijing, China, specializes in manufacturing smart cameras and developing AI-powered software for the logistics industry. The company produces a range of cameras, including the Mech-Eye Smart Camera, designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind's technology integrates 3D vision with artificial intelligence, enabling robots to recognize objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in addressing complex automation challenges, including logistics parcel picking and related operations. The company also maintains an office in Munich, Germany, and a sales office in Shanghai, China.
HAI ROBOTICS
Series C in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a variety of intelligent solutions, including a goods-to-person system, smart in-plant logistics solutions for manufacturing, and multi-tier steel platforms for diverse applications. As a pioneer in the field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, and has since focused on research and development, securing numerous patents. The HAIPICK system significantly enhances warehouse efficiency, reportedly increasing operational productivity by three to four times and boosting storage density by 80% to 130%. HAI ROBOTICS caters to a broad range of clients, including major logistics and supply chain companies, and is committed to delivering flexible and customizable automation solutions to optimize warehouse operations.
HAI ROBOTICS
Series D in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a variety of intelligent solutions, including a goods-to-person system, smart in-plant logistics solutions for manufacturing, and multi-tier steel platforms for diverse applications. As a pioneer in the field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, and has since focused on research and development, securing numerous patents. The HAIPICK system significantly enhances warehouse efficiency, reportedly increasing operational productivity by three to four times and boosting storage density by 80% to 130%. HAI ROBOTICS caters to a broad range of clients, including major logistics and supply chain companies, and is committed to delivering flexible and customizable automation solutions to optimize warehouse operations.
Syrius Robotics
Series B in 2021
Syrius Robotics, founded in 2018 and based in Shenzhen, China, specializes in manufacturing autonomous mobile robots for material handling in various sectors, including e-commerce, retail, and logistics. The company develops its own operational systems, software platforms, and AIoT cloud services to enhance the efficiency of fulfillment centers and warehouses worldwide. Utilizing advanced technologies such as Artificial Intelligence, laser radar, and camera systems, Syrius Robotics provides intelligent logistics solutions that improve productivity and streamline logistics management. Their products are increasingly adopted by a diverse range of commercial organizations beyond the transportation industry, showcasing the versatility of their automation solutions.
XtalPi Technology
Series D in 2021
XtalPi Inc. is a pharmaceutical technology company based in Cambridge, Massachusetts, with additional offices in China. Founded in 2014 by a team of quantum physicists from MIT, XtalPi focuses on transforming drug research and development through its Intelligent Digital Drug Discovery and Development (ID4) platform. This platform integrates quantum mechanics, artificial intelligence, and high-performance cloud computing to enhance the efficiency and accuracy of drug R&D processes. XtalPi's offerings include advanced tools for crystal structure prediction and determination, solid state testing, small molecule drug design, and AI model development. The company aims to accelerate drug discovery and development, thereby contributing to global health improvements. Its innovative technologies have garnered recognition within the industry and facilitated strategic partnerships with leading pharmaceutical companies.
Bota Biosciences
Series B in 2021
Bota Biosciences is a global industrial biotechnology company based in Hangzhou, China, founded in 2019. The company specializes in synthetic bioengineering technology for bio-manufacturing, focusing on developing efficient, eco-friendly, and cost-effective solutions. Bota Biosciences has created an integrative bioengineering platform that connects biological design to scale-up manufacturing, facilitating the transition to sustainable living. It operates its own pilot plant and manufacturing facility, which enhances its capacity to offer scalable industrial solutions and market-ready products across various sectors, including nutrition, food, personal care, and animal health. With a dynamic and multidisciplinary team, Bota Biosciences aims to channel biotechnology innovations for a global impact. The company has successfully raised substantial funding, exceeding $145 million, with investments from several prominent strategic and financial backers.
PhaBuilder
Angel Round in 2021
PhaBuilder is a platform-based & product-based company with advanced technology in synthetic biology, focusing on the transformation and engineering application of halophilic microbes. PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainly uses the cutting-edge "Next Generation Industrial Biotechnology(NGIB)" to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor. PhaBuilder currently has two PHA plants under construction - the synthetic biology intelligent development plant in Beijing China-Germany Industrial Park and the 10 kt/annum plant in Yichang, Hubei Province. It also plans to build up 3-5 large-scale production bases throughout China within five years. At present, PhaBuilder has completed two rounds of financing, raising around 300 million yuan in total. The investors include Sequoia Capital, China State-owned Enterprise Mixed Ownership Reform Fund, and GRC SinoGreen Fund, etc. In the future, PhaBuilder will constantly promote synthetic biotechnology to deeply integrate with people's lives and upgrade the intelligent biological manufacturing industry, in order to achieve PhaBuilder's core mission of "Using microbes to change the world and build a green future".
Cloudwise
Series E in 2021
Cloudwise, founded in 2009 and headquartered in Beijing, is a prominent provider of Artificial Intelligence for IT Operations (AIOps) solutions in China. The company has developed a comprehensive industrial landscape that includes IT operations, electric power IT operations, and IoT operations, encompassing various fields such as IT Operations Management (ITOM), IT Operations Analytics (ITOA), IT Service Management (ITSM), DevOps, and IoT. Cloudwise operates three research and development centers in Beijing, Yanjiao, and Zhengzhou, alongside operational centers in Shanghai, Guangzhou, and Chengdu. Additionally, it has branches in Hong Kong, Singapore, Thailand, and Malaysia, enabling it to provide marketing services and technical support throughout China and Southeast Asia. The company's cloud-based application performance management platform is designed to enhance business operations and decision-making, offering comprehensive performance testing, monitoring, and management services that help enterprises improve efficiency and profitability.
Westlake Therapeutics
Venture Round in 2021
Westlake Therapeutics is a biopharmaceutical company based in Hangzhou, China, founded in 2019. The company specializes in cell therapy, focusing on developing innovative treatments for rare diseases, cancer, and various immunological and metabolic disorders. Central to its approach is the REDx platform, which utilizes engineered red blood cell technology. This platform enables the genetic engineering of hematopoietic stem and progenitor cells sourced from peripheral blood, bone marrow, or cord blood. By leveraging this technology, Westlake Therapeutics aims to create personalized therapies that enhance treatment options for patients facing a wide range of health challenges.
HeyTea
Series D in 2021
HeyTea is a Chinese tea shop that specializes in cheese-topped tea and fruit tea. In 2012, HEYTEA originated from an alley in the riverside. Originally known as ROYALTEA , the royal tea was completely upgraded to the registered brand HEYTEA.
dMed
Series C in 2021
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
neoX BIOTECH
Venture Round in 2021
neoX BIOTECH is a biotechnology company established in 2018 and located in Beijing, China. The company specializes in the development of antigen-based cancer vaccines, leveraging a combination of artificial intelligence and biophysics to enhance drug research and development. neoX BIOTECH has created a neoantigen prediction and TCR screening platform that facilitates the discovery of effective macromolecular and multispecific drugs, particularly within the immuno-oncology sector. By characterizing protein-protein interactions, the company aims to advance early therapeutic discovery, ultimately improving treatment options for cancer patients.
AgileX
Venture Round in 2021
AgileX is a technology startup that provides mobile robot chassis and solutions for enterprises. It combines independent research and development, mass production, and global sales, and it is dedicated to helping the entire industry through mobile robots and liberating human productivity. The company's founding team and research and development team are drawn from industry leaders like DJI and Mathworks, as well as well-known scientific research institutions across the country. AgileX has created a number of development kits that cover "basic" to "advanced" applications, such as robot research and education kits, mobile grabbing robots, outdoor navigation solutions without prior waypoints, and automatic driving solutions. It has the potential to accelerate the research and development process for customers in the industry-wide application and scientific research education. The startup was established in 2017 and is based in Guangdong, China.
Chehaoduo
Series E in 2021
Chehaoduo designs an online car trading platform that sells used cars. Its online car trading platform directly links individual car sellers and buyers, which help buyers remove the middlemen as well as purchase used cars easily. Haoyong Yang founded Chehaoduo in 2014, with its headquarters in Beijing in China, with branches in Chinese cities such as Hangzhou and Chongqing.
Micro Connect
Series A in 2021
Micro Connect is a financial market platform that specializes in connecting global capital with China's micro and small businesses. The company focuses on enhancing liquidity in small business investments by providing professional investors with a new alternative to traditional impact investing. Micro Connect introduces Daily Revenue Obligations (DROs), an innovative asset class that allows investors to gain direct and diversified exposure to the daily cash flows of numerous retail establishments within China's dynamic consumer market. By facilitating access to capital for business owners, Micro Connect aims to create a more affordable financial ecosystem, while also offering structured product solutions and operating a licensed exchange.
Mech-Mind Robotics
Series C in 2021
Mech-Mind Robotics Technologies, founded in 2016 and based in Beijing, China, specializes in manufacturing smart cameras and developing AI-powered software for the logistics industry. The company produces a range of cameras, including the Mech-Eye Smart Camera, designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind's technology integrates 3D vision with artificial intelligence, enabling robots to recognize objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in addressing complex automation challenges, including logistics parcel picking and related operations. The company also maintains an office in Munich, Germany, and a sales office in Shanghai, China.
Beisen
Series F in 2021
Beijing Beisen Cloud Computing Co., Ltd. specializes in developing software as a service (SaaS) solutions for integrated talent management. Founded in 2005 and based in Beijing, the company offers a comprehensive platform that includes services for talent assessment, recruitment management, performance management, succession planning, and employee development. Beisen’s Human Resource Service Platform focuses on internet recruitment, while its Business People Service Network provides information and recruitment services. The company also delivers platform as a service (PaaS) for cloud architecture development, along with system implementation and custom development services. Its iTalentX platform features cloud-native applications designed to streamline human capital management (HCM) processes, enabling organizations to effectively recruit, evaluate, and retain talent throughout the employee lifecycle.
EdiGene
Series B in 2021
EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.
Qihan Biotech
Series A in 2021
Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation, and to solve the serious shortage of organ transplant donors in China and the world.
Neuracle
Series B in 2021
Neuracle is a prominent enterprise in China's neuroscience sector, specializing in neural monitoring and diagnostic technology. Leveraging advanced brain-machine interface technology developed in collaboration with Tsinghua University, Neuracle focuses on innovative research across neuroscience, psychology, and neuroengineering. The company provides comprehensive solutions for the diagnosis, treatment, and rehabilitation of clinical neurological diseases. Its product offerings include digital electroencephalographs that allow healthcare institutions to monitor patients' brain bioelectricity levels and facilitate accurate diagnoses of neural conditions. Neuracle's contributions span various fields, including clinical medicine and management marketing, and the company's research and development efforts have garnered recognition from experts in neuroscience and clinical medicine both domestically and internationally.
MetaX
Seed Round in 2021
Muxi is dedicated to providing full-stack GPU chips and heterogeneous computing solutions that can be widely used in cutting-edge fields such as artificial intelligence, smart cities, data centers, cloud computing, autonomous driving, digital twins, metaverse, and so on. It builds full-stack GPU chip products, launching MXN series GPUs (Xi Si) for AI reasoning, MXC series GPUs (Xi Yun) for AI training and general computing, and MXG series GPUs (Xi Cai) for graphics rendering, Meet the computing power requirements of data centers for "high energy efficiency" and "high versatility". Mu Xi's products all use independently developed GPU IP, have instruction sets and architectures with completely independent intellectual property rights, and are outfitted with a complete software stack (MACAMACA) compatible with mainstream GPU ecosystems. In September 2020, the company was founded in Shanghai, and it has wholly-owned subsidiaries and R&D centers in Beijing, Nanjing, Chengdu, Hangzhou, Shenzhen, and Wuhan.
Tim Hortons China
Venture Round in 2021
Tim Hortons China operates a chain of coffee restaurants, providing a range of coffee and food products, including made-to-order shrimp sandwiches and salads, primarily through its outlets in Shanghai. Established in 2018, the company is based in Shanghai and functions as a subsidiary of Tim Hortons Inc. In addition to its physical locations, Tim Hortons China also offers online shopping options for its products, ensuring convenience for customers. The company maintains communications with its clientele through various channels, including phone, email, and online applications, to address inquiries and enhance customer service.
Furong Xingsheng
Venture Round in 2021
Furong Xingsheng, founded in 2009 and based in Changsha, China, operates a network of convenience stores that focus on community shopping. The company offers a variety of fresh products, including vegetables, fruits, meat, poultry, seafood, and general merchandise. It employs a novel retail model that combines online ordering with offline pick-up, catering to the daily needs of household consumers. In addition to its retail operations, Furong Xingsheng also specializes in B2B logistics and distribution services, enhancing its efficiency in serving the local market.
Neurophth Therapeutics
Series B in 2021
Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.
Babycare
Series B in 2021
Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.
neoX BIOTECH
Series A in 2021
neoX BIOTECH is a biotechnology company established in 2018 and located in Beijing, China. The company specializes in the development of antigen-based cancer vaccines, leveraging a combination of artificial intelligence and biophysics to enhance drug research and development. neoX BIOTECH has created a neoantigen prediction and TCR screening platform that facilitates the discovery of effective macromolecular and multispecific drugs, particularly within the immuno-oncology sector. By characterizing protein-protein interactions, the company aims to advance early therapeutic discovery, ultimately improving treatment options for cancer patients.
Xiaobangguihua
Series B in 2021
XiaoBangGuiHua is an intelligent investment advisory service platform designed to assist Chinese middle-class families in managing their finances more effectively. The platform employs artificial intelligence algorithms and advanced asset allocation models to deliver systematic financial management solutions. It offers a variety of services, including personalized consultations and educational resources focused on financial risk management. Through its innovative approach, XiaoBangGuiHua aims to empower investors by providing them with the tools and knowledge necessary to enhance their financial decision-making and optimize their investment strategies.
Lalamove
Series F in 2021
Originally known as EasyVan, Lalamove was launched to satisfy a specific logistical need - van hire. Started in Hong Kong in December 2013, Lalamove operates in 21 markets across Asia and Latin America connecting over 7 million customers with a pool of over 700,000 driver-partners. The Lalamove way has revolutionized old van hiring call centers to being so streamlined, customers and drivers match with each other within 12 seconds. Local deliveries are fulfilled at a breakneck 55 minutes, door-to-door. Providing reliable and quick deliveries for customers, Lalamove also optimises drivers fleet and route to maximise their earning potential.
NuProbe
Series B in 2021
NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.
Hive Box Technology
Series C in 2021
Founded in 2015 and based in Shenzhen, China, Hive Box Technology operates a network of self-service package drop-off and pick-up stations primarily aimed at enhancing the logistics of express delivery and e-commerce. The company has developed a 24-hour self-service platform that allows customers to conveniently store and retrieve packages at their leisure, thereby improving the efficiency of package handling in residential areas. By focusing on accessibility and user experience, Hive Box facilitates seamless interactions between consumers and logistics services, positioning itself as a key player in the evolving landscape of package delivery in China.
STARLINK
Series B in 2021
STARLINK is an online technology company based in Shenzhen, China, with additional offices in Chengdu and Xuzhou. Founded in 2017, the company focuses on developing an e-commerce platform that leverages technology to streamline and integrate China's high-quality supply chain. STARLINK provides a variety of products for the overseas market, including apparel, footwear, and home and outdoor items. The company's goal is to connect global users with quality industrial products while enhancing the efficiency of the supply chain.
Insight Lifetech
Series C in 2020
Insight Lifetech is a medical technology company focused on creating innovative solutions for the diagnosis and treatment of cardiovascular diseases. It has developed a synergistic platform that integrates research and development, manufacturing, and commercialization, which enhances collaboration, accelerates product development, and promotes cost efficiency. The company is notable for creating the first and only domestic fractional flow reserve (FFR) system in China that has received approval from the National Medical Products Administration (NMPA). By manufacturing high-quality medical devices that feature reliable precision diagnostics and therapeutic capabilities, Insight Lifetech aims to empower physicians to improve patient outcomes and save lives.
Zuoyebang
Series E in 2020
Zuoyebang is an online education startup based in Beijing, China, founded in 2014 by Hou Jianbin. The company focuses on providing educational products and services for primary and high school students, utilizing artificial intelligence to enhance learning experiences. Its platform allows students to upload homework questions and seek answers, making it easier for them to tackle study-related challenges. In addition to homework assistance, Zuoyebang offers online courses, live lessons, and evaluations for students from kindergarten through 12th grade. The company has gained significant backing from prominent investors, including Baidu, Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.
Lalamove
Series E in 2020
Originally known as EasyVan, Lalamove was launched to satisfy a specific logistical need - van hire. Started in Hong Kong in December 2013, Lalamove operates in 21 markets across Asia and Latin America connecting over 7 million customers with a pool of over 700,000 driver-partners. The Lalamove way has revolutionized old van hiring call centers to being so streamlined, customers and drivers match with each other within 12 seconds. Local deliveries are fulfilled at a breakneck 55 minutes, door-to-door. Providing reliable and quick deliveries for customers, Lalamove also optimises drivers fleet and route to maximise their earning potential.
Huolala
Series E in 2020
Huolala offers logistics services, moving, less-than-truckload, car rental and sales, and after-car services. Founded in 2013 and grown in the Guangdong-Hong Kong-Macao Greater Bay Area.
dMed
Series C in 2020
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
CassTime
Series C in 2020
CassTime is an industrial internet company based in China that focuses on the automotive aftermarket. It operates a comprehensive trading platform that offers full coverage of spare parts, facilitating price inquiries and simplifying settlements for sellers of auto parts and accessories. In addition to its marketplace, CassTime provides a SaaS management system tailored for workshops, along with supply chain finance and logistics services. This integrated approach enables businesses to conduct transactions efficiently while accessing detailed information about vehicle parts, ultimately enhancing the overall experience for both buyers and sellers in the automotive sector.
SciNeuro
Series A in 2020
SciNeuro Pharmaceuticals is a biotechnology company based in Shanghai, China, focused on developing innovative medicines for patients with central nervous system (CNS) diseases. The company is committed to transforming the treatment landscape for these conditions through a robust product pipeline that emphasizes internal innovation and global collaboration. SciNeuro's drug development is guided by breakthrough scientific evidence, including insights from human genetics and pharmacology, targeting the underlying mechanisms of CNS diseases. By addressing these pathological mechanisms, SciNeuro aims to provide transformative therapies that not only aim to cure these diseases but also enhance the quality of life for patients.
Cloudwise
Series D in 2020
Cloudwise, founded in 2009 and headquartered in Beijing, is a prominent provider of Artificial Intelligence for IT Operations (AIOps) solutions in China. The company has developed a comprehensive industrial landscape that includes IT operations, electric power IT operations, and IoT operations, encompassing various fields such as IT Operations Management (ITOM), IT Operations Analytics (ITOA), IT Service Management (ITSM), DevOps, and IoT. Cloudwise operates three research and development centers in Beijing, Yanjiao, and Zhengzhou, alongside operational centers in Shanghai, Guangzhou, and Chengdu. Additionally, it has branches in Hong Kong, Singapore, Thailand, and Malaysia, enabling it to provide marketing services and technical support throughout China and Southeast Asia. The company's cloud-based application performance management platform is designed to enhance business operations and decision-making, offering comprehensive performance testing, monitoring, and management services that help enterprises improve efficiency and profitability.
Moore Threads
Seed Round in 2020
Moore Threads, founded in 2020 and based in Beijing, China, specializes in developing Graphics Processing Unit (GPU) technology and services. The company focuses on enabling visual computing, artificial intelligence, and high-performance computing applications for a diverse range of sectors, including gaming and the creative industry. By providing advanced GPU technology and services for data centers, edge computing servers, professional workstations, and high-performance PCs, Moore Threads helps clients achieve significant computational power for their processes.
Jiangxing Intelligence
Series A in 2020
Jiangxing Intelligence Inc., founded in 2018 by Professor Liu Jiangchuan, specializes in the development and operation of artificial intelligence (AI) and edge computing technologies tailored for the Internet of Things (IoT) in China. The company offers solutions such as EdgeBox, which enables real-time processing of big data for industrial clients across various sectors, including manufacturing, energy, transportation, and smart cities. Additionally, its Ubiquitous Wisdom Eye device provides intelligent monitoring for transmission lines by integrating data from various sensors, creating a cohesive supervision platform. Headquartered in Beijing, with offices in Shenzhen and Nanjing, Jiangxing Intelligence has secured significant venture capital funding, positioning itself as a leader in advanced edge computing applications for energy and industrial security.
Zhiketong Technology
Series D in 2020
Beijing Zhiketong Technology Co., Ltd., established in 2014, specializes in providing direct marketing services for the hospitality, leisure, and entertainment sectors through its web platform on WeChat. The company acts as an agency that offers a range of digital marketing solutions, including consulting, advertising, and comprehensive data analysis. By assisting partners in optimizing their management efficiency and enhancing service quality, Zhiketong Technology helps businesses increase brand awareness and attract more customers. Its services encompass intelligent data analysis systems, online marketing strategies, customer management tools, and online store design, all aimed at driving revenue growth for hotels and tourism attractions in China.
SmartSens Technology
Series B in 2020
SmartSens Technology is a company based in Shanghai that specializes in the research, development, design, and sales of high-performance CMOS image sensor chips. The company provides advanced imaging solutions tailored for diverse applications such as surveillance, machine vision, automotive, and cellphone cameras. By focusing on product innovation, SmartSens aims to enhance growth across various industries with a comprehensive portfolio of image sensors.
EdiGene
Series B in 2020
EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.
BambooCloud
Series C in 2020
Shenzhen BambooCloud Technology Co., Ltd. is a security management enterprise specializing in identity management and access control solutions. Headquartered in Shenzhen, China, with additional offices in major cities such as Beijing and Shanghai, BambooCloud has developed a comprehensive security platform that includes cloud application security management. The company offers consulting services, customized solutions, and SaaS products focused on enhancing enterprise information system security and management control for clients primarily in Europe, America, and ASEAN regions. Their proprietary identity management platform automates identity processes and provides multi-factor authentication for critical business transactions, ensuring effective control over user access privileges. This scalable solution supports both cloud and on-premise deployments, addressing compliance requirements while improving cyber resilience and user convenience.
XtalPi Technology
Series C in 2020
XtalPi Inc. is a pharmaceutical technology company based in Cambridge, Massachusetts, with additional offices in China. Founded in 2014 by a team of quantum physicists from MIT, XtalPi focuses on transforming drug research and development through its Intelligent Digital Drug Discovery and Development (ID4) platform. This platform integrates quantum mechanics, artificial intelligence, and high-performance cloud computing to enhance the efficiency and accuracy of drug R&D processes. XtalPi's offerings include advanced tools for crystal structure prediction and determination, solid state testing, small molecule drug design, and AI model development. The company aims to accelerate drug discovery and development, thereby contributing to global health improvements. Its innovative technologies have garnered recognition within the industry and facilitated strategic partnerships with leading pharmaceutical companies.
Recurrent.ai
Series B in 2020
Recurrent.ai is a Chinese company that specializes in AI-enabled corporate services aimed at enhancing sales efficiency. The company offers a comprehensive sales dialogue analysis system that converts voice interactions into text, facilitating in-depth analysis of sales calls and customer service conversations. By leveraging machine learning, Recurrent.ai helps businesses generate detailed big data dialogue analysis reports and maintain customer portrait records. These capabilities enable companies to optimize their sales processes, reduce labor costs, and improve sales conversion rates, ultimately supporting more informed decision-making.
Xreal
Series B in 2020
Xreal is a developer of mixed reality technology based in Beijing, China, founded in 2017. The company specializes in creating lightweight mixed reality glasses, with its flagship product, Nreal Light, designed for comfort and vivid display quality. These glasses utilize advanced spatial computing algorithms and environment-understanding AI to deliver an immersive user experience. Xreal aims to make mixed reality technology accessible to a broader audience, while also empowering developers to create innovative applications that enhance entertainment and productivity. Through its products and initiatives, Xreal seeks to unlock the full potential of mixed reality in everyday life.
LP Pharmaceuticals
Series C in 2020
LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.
Dizal Pharma
Venture Round in 2020
Dizal Pharmaceutical is a research-focused biotechnology company that specializes in the discovery, development, and commercialization of innovative medicines. The company is involved in all stages of drug development, from research and development to production and sales, aiming to create first-in-class and best-in-class therapeutic solutions. Based in Jiangsu, China, Dizal Pharmaceutical is committed to advancing healthcare through its innovative drug portfolio.
STARLINK
Series A in 2020
STARLINK is an online technology company based in Shenzhen, China, with additional offices in Chengdu and Xuzhou. Founded in 2017, the company focuses on developing an e-commerce platform that leverages technology to streamline and integrate China's high-quality supply chain. STARLINK provides a variety of products for the overseas market, including apparel, footwear, and home and outdoor items. The company's goal is to connect global users with quality industrial products while enhancing the efficiency of the supply chain.
WeShine
Series A in 2020
WeShine is a marketing and service platform that specializes in corporate account management solutions, primarily utilizing WeChat to enhance customer acquisition for businesses. Established in 2015 and headquartered in Nanjing, China, WeShine has successfully served over 150,000 businesses, with more than 30,000 of these being paid enterprise users. The platform focuses on integrated marketing and media services that leverage social media to enable mobile interaction and digital content sharing, helping clients to expand their customer base and improve marketing accuracy. With a global network of over 600 channel partners, WeShine operates offices in several major Chinese cities, including Guangzhou, Shenzhen, Beijing, Shanghai, Wuxi, and Wuhan.
Furong Xingsheng
Series C in 2020
Furong Xingsheng, founded in 2009 and based in Changsha, China, operates a network of convenience stores that focus on community shopping. The company offers a variety of fresh products, including vegetables, fruits, meat, poultry, seafood, and general merchandise. It employs a novel retail model that combines online ordering with offline pick-up, catering to the daily needs of household consumers. In addition to its retail operations, Furong Xingsheng also specializes in B2B logistics and distribution services, enhancing its efficiency in serving the local market.
Xpeng Motors
Series C in 2020
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.
Tungee
Series B in 2020
Tungee, established in 2016, is a provider of intelligent sales solutions for business-to-business enterprises. By utilizing big data and artificial intelligence technologies, including natural language processing and machine learning, Tungee offers a comprehensive platform that facilitates lead mining, business opportunity engagement, customer relationship management, and order analysis. This platform is designed to help enterprises efficiently identify, contact, and manage customers, thereby reducing customer acquisition costs and enhancing overall sales performance. Tungee has positioned itself as a leader in the Chinese intelligent sales sector, serving over 3,000 enterprise clients, including notable companies such as Alibaba and China Mobile. Through its innovative approach, Tungee addresses the challenges faced by businesses in sales forecasting and customer management.
AccuMedical
Series B in 2020
AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.
neoX BIOTECH
Venture Round in 2020
neoX BIOTECH is a biotechnology company established in 2018 and located in Beijing, China. The company specializes in the development of antigen-based cancer vaccines, leveraging a combination of artificial intelligence and biophysics to enhance drug research and development. neoX BIOTECH has created a neoantigen prediction and TCR screening platform that facilitates the discovery of effective macromolecular and multispecific drugs, particularly within the immuno-oncology sector. By characterizing protein-protein interactions, the company aims to advance early therapeutic discovery, ultimately improving treatment options for cancer patients.
Zuoyebang
Series E in 2020
Zuoyebang is an online education startup based in Beijing, China, founded in 2014 by Hou Jianbin. The company focuses on providing educational products and services for primary and high school students, utilizing artificial intelligence to enhance learning experiences. Its platform allows students to upload homework questions and seek answers, making it easier for them to tackle study-related challenges. In addition to homework assistance, Zuoyebang offers online courses, live lessons, and evaluations for students from kindergarten through 12th grade. The company has gained significant backing from prominent investors, including Baidu, Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.